Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1989-8-23
pubmed:abstractText
An enzyme immunoassay (EIA) for anti-hepatitis B core (HBc) immunoglobulin G1 (IgG1) was compared with a commercial radioimmunoassay (RIA) for anti-HBc antibody (Corab: Abbott Laboratories, North Chicago, Ill.). In parallel tests of 445 consecutive samples, discrepant results were obtained with 2 samples, 1 of which was positive only by the RIA and the other of which was positive only by the EIA for anti-HBc IgG1. In tests of another 192 samples with low blocking activity in the RIA (inhibition range, 90 to 30%), 10 samples gave discrepant results, 5 of which were positive only by the RIA and the other 5 of which were positive only by the EIA for anti-HBc IgG1. Of 12 samples with discrepant results, 11 samples were tested further for anti-HBc IgG3, IgM, and IgA1 by the EIA. Of these, seven samples were positive for anti-HBc IgG1, anti-HBc IgG3, or both. All seven samples were also positive for anti-hepatitis B surface (HBs) antigen. Three samples were negative for anti-HBc IgG1, anti-HBc IgG3, or both but were positive for anti-HBc IgM, anti-HBc IgA1, or both; and one sample was reactive only in the RIA. These four samples were all negative for anti-HBs. Thus, low-level results in the RIA caused by anti-HBc IgM, anti-HBc IgA, or both reflect the unspecific activation of immature B lymphocytes that is not related to previous exposure to hepatitis B virus (HBV). In contrast, the presence of anti-HBc IgG1, anti-HBc IgG3, or both indicates differentiated anti-HBc IgG-producing plasma cells and previous exposure to HBV, as was also shown by the presence of anti-HBs. On class and subclass determination for confirmation of positivity for anti-HBc in 19 serum samples, which was identified by screening of blood from 1,343 donors by a competitive EIA (Hepanostika; Organon), 9 samples with positive results, all low level, did not indicate previous exposure to HBV. It was concluded that determination of classes and subclasses of anti-HBc provides a tool for discriminating positive anti-HBc results not caused by HBV exposure.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-2957523, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3006567, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3029317, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3101245, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3101289, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3103271, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3491425, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3544369, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3643677, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3762540, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-3881467, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-4627513, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-5103349, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6086711, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6332844, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6437308, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6698624, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6706423, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6715519, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6776136, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6832810, http://linkedlifedata.com/resource/pubmed/commentcorrection/2663917-6894613
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
849-53
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1989
pubmed:articleTitle
Enzyme immunoassay for anti-hepatitis B core (HBc) immunoglobulin G1 and significance of low-level results in competitive assays for anti-HBc.
pubmed:affiliation
Department of Virology, National Bacteriological Laboratory, Stockholm, Sweden.
pubmed:publicationType
Journal Article